Ditchcarbon
  • Contact
  1. Organizations
  2. Harrow, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 17 days ago

Harrow, Inc.

Company website

Harrow, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States and operates primarily in the specialty pharmaceuticals sector. Founded in 2013, the company has made significant strides in developing innovative treatments, particularly in the areas of ophthalmology and other niche therapeutic markets. Harrow's core offerings include a range of proprietary prescription eye medications, distinguished by their unique formulations and delivery methods. The company has established a strong market position, recognised for its commitment to improving patient outcomes through advanced drug development. With a focus on quality and efficacy, Harrow continues to achieve notable milestones, solidifying its reputation as a trusted name in specialty pharmaceuticals.

DitchCarbon Score

How does Harrow, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

19

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Harrow, Inc.'s score of 19 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

19%

Let us know if this data was useful to you

Harrow, Inc.'s reported carbon emissions

Harrow, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, Harrow, Inc. has not established any formal reduction targets or initiatives, including those aligned with the Science Based Targets initiative (SBTi). The company has not made any public climate pledges or commitments to reduce its carbon footprint. As a result, Harrow, Inc. appears to be in the early stages of developing a comprehensive climate strategy, which is increasingly important in today's environmentally conscious market. Without specific emissions data or reduction targets, it is challenging to assess the company's impact on climate change or its commitment to sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Harrow, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Harrow, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Harrow, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bd

US
•
Glass and glass products
Updated about 19 hours ago

Revvity

US
•
Health and social work services (85)
Updated 3 days ago

Allergan

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 19 days ago

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

F. Hoffmann-La Roche AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251023.18
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy